HJB647 / Novartis - LARVOL DELTA

HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension (clinicaltrials.gov) - P1 | N=64 | Recruiting | Sponsor: Novartis Pharmaceuticals | Not yet recruiting ➔ Recruiting

Enrollment open • Cardiovascular • Hypertension

HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension (clinicaltrials.gov) - P1 | N=74 | Not yet recruiting | Sponsor: Novartis Pharmaceuticals

New P1 trial • Cardiovascular • Hypertension

A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: Novartis Pharmaceuticals | Not yet recruiting ➔ Recruiting

Enrollment open • Cardiovascular • Congestive Heart Failure • Heart Failure